Microradiopharmaceutical for Metastatic Melanoma
- 23 October 2017
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 34 (12) , 2922-2930
Abstract
Purpose The purpose of this article was to develop, characterize and test (in vivo) dacarbazine microparticles that may be labeled with 99mTc and Ra-223 for both use: diagnostic and therapy of metastatic melanoma. Methods We developed by double emulsion solvent evaporation methodology the microparticle. The characterization has been done using, Dynamic Light Scattering (DLS) and Scanning Electron Microscopy (SEM). The labeling with 99mTc and Ra-223 has been done by the direct labeling process. Also the formulation has been tested pre-clinically using Balb/c mice inducted with melanoma, performing the the biodistribution and planar imaging. Cytotoxicity evaluation was also done in M3 V cell line. In order to understand the safety aspects of the microparticles, microbiological study (endotoxin and sterility) has been done. Finally, planar imaging was performed to evaluate the diagnosing aspect. Results The results showed that a 559 nm microparticles was obtained with a spherical shape. The labeling process with 99mTc reached over 90% of efficacy. On the other hand, the labeling process with Ra-223 showed a 70% efficacy. The results in inducted animals demonstrated that the microparticles were able to reach the tumor with a high rate (20%). Also demonstrated a low recognition by the Mononuclear Phagocytic System. The cytotoxicity and the microbiological control, corroborates the safety aspect of these microparticles. Conclusion The planar image and the possible labeling with Ra-223, corroborates the use as a theragnostic agent for imaging and therapy of Metastatic Melanoma.Keywords
Funding Information
- CNPq
- FAPERJ
- FAPESP
This publication has 26 references indexed in Scilit:
- In vivo studies: comparing the administration via and the impact on the biodistribution of radiopharmaceuticalsNuclear Medicine and Biology, 2014
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Redox Modulation of FAK Controls Melanoma Survival - Role of NOX4PLOS ONE, 2014
- Loss of orally administered drugs in GI tractSaudi Pharmaceutical Journal, 2012
- UVA, UVB and incidence of cutaneous malignant melanoma in Norway and SwedenPhotochemical & Photobiological Sciences, 2011
- Gd‐Labeled Microparticles in MRI: In vivo Imaging of Microparticles After Intraperitoneal InjectionSmall, 2010
- A new understanding in the epidemiology of melanomaExpert Review of Anticancer Therapy, 2010
- Epidemiology and aetiology of basal cell carcinomaBritish Journal of Dermatology, 2007
- Metastatic Malignant Melanoma of the Gastrointestinal TractMayo Clinic Proceedings, 2006
- Genetic pathways to melanoma tumorigenesisJournal of Clinical Pathology, 2004